Dog IMHA: Immune-Mediated Hemolytic Anemia Signs to Know

Immune-mediated hemolytic anemia (IMHA) is a life-threatening condition where a dog's immune system destroys its own red blood cells. It is one of the most common causes of severe anemia in dogs and requires rapid hospitalization and aggressive immunosuppressive treatment. Without treatment, mortality can be 30–70% depending on severity.

Last reviewed: June 2026

What Is IMHA in Dogs?

IMHA occurs when the immune system produces antibodies that attack and destroy the dog's own red blood cells (RBCs), causing acute or subacute hemolytic anemia. It can be:

• Primary (idiopathic) IMHA: No identifiable trigger — the most common form, accounting for about 60–75% of cases
• Secondary IMHA: Triggered by an underlying cause — infections (Ehrlichia, Babesia, Leishmania), drugs (certain antibiotics, NSAIDs), neoplasia, or vaccine reactions

Certain breeds are predisposed to primary IMHA, including Cocker Spaniels, Springer Spaniels, Poodles, Irish Setters, and Doberman Pinschers.

The American College of Veterinary Internal Medicine consensus guidelines emphasize that prompt diagnosis and rapid initiation of immunosuppressive therapy are the most important determinants of survival (ACVIM Consensus Statement on IMHA, 2019).

Signs of IMHA in Dogs

Signs reflect acute, severe anemia and RBC destruction:

• Extreme weakness and lethargy — often sudden in onset
• Pale or white gums (pallor is the most reliable sign of anemia)
• Yellow tinge to skin, gums, or whites of eyes (jaundice — from bilirubin released by destroyed RBCs)
• Rapid breathing or increased respiratory rate (compensating for low oxygen-carrying capacity)
• Dark orange or brown urine (hemoglobinuria — RBCs destroyed in the bloodstream release hemoglobin)
• Rapid or irregular heart rate
• Collapse or sudden onset of profound weakness

IMHA can develop over hours to days. By the time an owner notices the signs, the anemia is often already severe. A packed cell volume (PCV) below 15% is associated with significantly worse outcomes.

Treatment of Canine IMHA

Hospitalization and stabilization:

• IV fluids to support blood pressure and organ perfusion
• Blood transfusion if PCV is critically low (typically < 12–15%)
• Oxygen supplementation

Immunosuppression: High-dose prednisolone (2 mg/kg/day) is the first-line drug. Second-line agents — azathioprine, cyclosporine, mycophenolate — are added in severe, refractory, or rapidly deteriorating cases. As described in Ettinger's Textbook of Veterinary Internal Medicine, response to prednisolone monotherapy is seen in roughly 50–70% of primary IMHA cases.

Anti-thrombotic therapy: IMHA carries a very high risk of thromboembolism (pulmonary embolism, splenic infarcts). Aspirin or heparin therapy is now standard practice alongside immunosuppression.

Treatment duration: Immunosuppressives are tapered slowly over 3–6 months once remission is confirmed. Relapses occur in up to 30% of dogs.

When to See a Vet

Call your vet today if:

• Your dog's gums look pale, white, or very light pink
• Your dog is suddenly weak, lethargic, or reluctant to move
• You notice yellowing of the gums, eyes, or belly skin
• Your dog's urine has turned orange, brown, or tea-colored

Go to the ER immediately if:

• Collapse, inability to stand, or loss of consciousness
• Rapid or labored breathing
• Your dog's gums are white, bluish, or brick-red
• Any combination of sudden weakness + jaundice + abnormal urine color — this is an emergency

Frequently Asked Questions

How much does treating IMHA in dogs cost? IMHA treatment is expensive because it requires intensive hospitalization. Initial emergency workup (bloodwork, PCV, urinalysis, imaging) runs $400–800. A blood transfusion adds $500–1,200 per unit. Hospital stays of 3–7 days cost $1,500–4,000. Total first-episode cost is commonly $3,000–8,000. Long-term immunosuppressant medications and monitoring add $100–300 per month during the treatment phase.

Can dogs survive IMHA? With prompt, aggressive treatment, many dogs do survive — studies report survival rates of 50–80% for dogs that respond to initial therapy. The prognosis is better for primary IMHA versus secondary IMHA driven by an underlying cancer. Relapses occur in up to 30% of survivors.

Is IMHA in dogs preventable? Primary IMHA cannot currently be prevented. Secondary IMHA from certain drug reactions can sometimes be avoided by using alternative medications in predisposed breeds. Routine tick prevention may reduce risk from tick-borne IMHA triggers.

What is the difference between IMHA and anemia from blood loss? Blood-loss anemia (from trauma or bleeding ulcers) causes pale gums but not jaundice or dark urine. IMHA causes all three — pallor, jaundice, and hemoglobinuria — because RBCs are being destroyed rather than just lost. A vet can distinguish them with bloodwork and a urine test.

How long does IMHA treatment take? Induction of remission typically takes 2–4 weeks in the hospital or with intensive outpatient visits. Immunosuppressive drugs are then tapered over 3–6 months. Dogs are considered to be in sustained remission after 12 months off all medication without relapse.

Still Not Sure if Your Dog Needs a Vet?

When you're not sure if this is wait-and-see or call-tonight, Voyage AI Vet triages in under 2 minutes. Describe what you're seeing in chat, share photos of your dog's gums, eye whites, and overall posture, or hop on a live video call if you want a second pair of eyes. Every answer comes with citations to the actual veterinary literature it's pulling from — so you see exactly where the guidance comes from, not just a chatbot's word.

Start a triage →